The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Even if chloroquine and hydroxychloroquine don't end up being the best treatment for COVID-19, observing how they work in a dish can teach scientists a lot.
Research shows that misshapen proteins called prions can help yeast cells survive environmental threats, such as a lack of food and common antifungal drugs.
The discovery of a giant cavity in a key tuberculosis molecule could open the way for better understanding of the disease.
Co-infection with SARS-CoV-2 and other respiratory pathogens is more common than previously expected, according to a Stanford study.
A look at how viruses — including coronavirus — enter cells, use their molecular machinery to copy themselves and escape. And how to stop them.
Amid the COVID-19 pandemic, viruses are getting a lot of attention; here's an inside look into the most abundant life form on Earth.
Most children with antibiotic-resistant urinary tract infections get better on less powerful antibiotics than lab tests say they need, says Stanford study.
A stress test helps researchers distinguish between different kinds of bacteria by testing their cell wall strength under pressure.
Stanford researchers examined how people react to museum exhibits offering an immersive experience with the single-cell organism Euglena.
Scientists have used CRISPR-Cas9 screens to reveal more about how the bacteria behind Legionnaire's disease infects humans.
The best time to get a flu shot is when you haven't had antibiotics recently, a new study has found, because healthy gut bacteria protect immunity.
The conclusion of this series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics really improve health.
This two-part series examines the benefits, and drawbacks, of probiotics. Stanford researchers clarify whether probiotics can really boost your health.
During a recent episode of "The Future of Everything," host Russ Altman and guest Ami Bhatt discuss the factors that contribute to microbiome health.
The bacteria in our gut make tiny, previously unidentified proteins that could shed light on human health and advance drug development.